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ABSTRACT 
Objective:  A novel family of proton sensing G-protein coupled receptors (GPCRs), 
including OGR1, GPR4, and TDAG8 was identified to be important for physiological pH 
homeostasis and inflammation. Thus we determined the function of proton-sensing OGR1 
in the intestinal mucosa. 
Design: OGR1 expression in colonic tissues was investigated in controls and IBD patients. 
Expression of OGR1 upon cell activation was studied in the Mono Mac 6 (MM6) cell line 
and primary human and murine monocytes by real-time PCR. Ogr1 knockout mice were 
crossbred with Il-10 deficient mice and studied over 200 days. Microarray profiling was 
performed using Ogr1-/- and Ogr1+/+ (WT) residential peritoneal macrophages.  
Results: IBD patients expressed higher levels of OGR1 in the mucosa than non-IBD 
controls. Treatment of MM6 cells with TNF, led to significant up-regulation of OGR1 
expression, which could be reversed by the presence of NF-κB inhibitors. Kaplan-Meier 
survival analysis showed a significantly delayed onset and progression of rectal prolapse 
in female Ogr1-/-// Il-10-/- mice. These mice displayed significantly less rectal prolapses. 
Up-regulation of gene expression, mediated by OGR1, in response to extracellular 
acidification in mouse macrophages was enriched for inflammation and immune 
response, actin cytoskeleton, and cell adhesion gene pathways.  
Conclusion: OGR1 expression is induced in cells of human macrophage lineage and 
primary human monocytes by TNF. NF-κB inhibition reverses the induction of OGR1 
expression by TNF. OGR1 deficiency protects from spontaneous inflammation in the Il-10 
KO model. Our data indicate a pathophysiological role for pH-sensing receptor OGR1 
during the pathogenesis of mucosal inflammation. 
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factor; UC, Ulcerative colitis. 
 
Grants: This work was supported by a collaborative grant from the Zürich Center for 
Integrative Human Physiology (ZIHP) to CW and GR, research grants from the Swiss 
National Science Foundation to GR (Grant No.314730-153380) and the Swiss IBD Cohort 
(Grant No 3347CO-108792). The funding institutions had no role in the study design, in 
the collection, analysis and interpretation of data and in the writing of the manuscript. 
 
Competing interests: The authors declare no competing interests. 
 
Author contributions: CdV performed experiments, analyzed the data and wrote the first 
draft of the manuscript;  YW, SV, IC, MRS, IT, AT,  M-GL, TS, performed experiments and 
were involved in data analysis, MF, GAK-U, IF-W, MS, JJE, KS, CAW, GR conceived, designed 
and supervised the study and respective experiments. All authors wrote, corrected and 
approved the manuscript. 
  
Manuscript I 
49 
INTRODUCTION  
The mechanisms involved in the maintenance of mucosal homeostasis are important in 
our understanding of the pathophysiology of inflammatory bowel disease (IBD). Both 
forms of the disease, Crohn’s disease (CD) and ulcerative colitis (UC), give rise to 
inflammation that is associated with extracellular acidification of mucosal tissue. Mucosal 
inflammation is interpreted as a local response to tissue damage and microbial invasion. 
A number of studies suggest that an acidic environment affects the progression and 
resolution of inflammation.1-3 Inflammation has been attributed to an increase in local 
proton concentration and lactate production4 and subsequent pro-inflammatory cytokine 
production, such as tumour necrosis factor (TNF), interleukin-6 (IL-6), interferon-gamma 
(IFN-γ) and interleukin-1-beta (IL-1β). TNF is one of the characterizing cytokines in IBD5, 
6 and anti-TNF targeted therapies are successful in both CD and UC.7-10 Activated 
macrophages, which are key cellular mediators of acute and chronic inflammation, are 
primary producers of TNF11. TNF activates the nuclear transcription factor kappa B (NF-
κB), one of the key regulators in chronic mucosal inflammation.12, 13 
G-protein-coupled receptors (GPCRs), cell-surface molecules involved in signal 
transduction, are targeted by key inflammatory cytokines.14 The ovarian cancer G-protein 
coupled receptor 1 (OGR1) family of receptors, which include OGR1, G protein coupled 
receptor 4 (GPR4), and T-cell death associated gene (TDAG8), sense extracellular protons 
through histidine residues located on the extracellular region of the receptors, resulting 
in the modification of a variety of cell functions.15, 16 Early signaling pathways of pH-
sensing receptors triggered by acidification include phospholipase C activation, inositol 
trisphosphate formation and subsequent Ca2+ release15 or cyclic adenosine 
monophosphate (cAMP) production.17, 18 The increase of intracellular calcium influx and 
accumulation of cAMP has been shown to regulate a vast range of cellular responses. 
Moreover, OGR1 and TDAG8 are alleged to act in opposition in a regulatory manner, either 
enhancing or inhibiting the production of proinflammatory cytokines respectively.19 
TDAG8 mediated extracellular acidification inhibited lipopolysaccharide (LPS)-induced 
production of TNF and IL-6 in mouse peritoneal inflammatory macrophages.2 Patients 
with CD demonstrate a defect in macrophage function resulting in an inadequate bacterial 
clearance from inflammatory sites.20 In addition, macrophages from CD patients showed 
impaired TNF-alpha secretion in response to bacterial challenge.21 Furthermore, 
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association results and in silico analysis have recently identified a locus within the TDAG8 
gene as one of the susceptibility loci associated with CD.22 Onozawa et al. suggest that 
TDAG8 is a negative regulator of inflammation23, which is mediated via a Gs-coupled 
mechanism.2 In contrast, OGR1 is reported to act predominately via a Gq-coupled 
mechanism to stimulate proinflammatory cytokines production upon extracellular 
acidification.19 
To date, few data on the role of OGR1 in inflammation in IBD have been published. OGR1 
may play an important role in the regulation of the inflammatory pathways in IBD, and it 
may represent an interesting target for innovative therapies. Therefore, we investigated 
the role and function of OGR1 in gut inflammation, with a focus on myeloid cells. We used 
an immune-mediated inflammatory disease mouse model, namely interleukin-10 (Il-10) 
knockout (KO) mice, which spontaneously develop chronic colitis24-26 and a human 
monocyte model. We show that OGR1 expression is induced in monocytes by TNF and 
Ogr1 deficiency protects from spontaneous inflammation in the Il-10 KO model.  
Materials and Methods 
Details of reagents used and methods for gene expression are provided in the 
Supplementary Materials and Methods section. 
pH experiments 
pH shift experiments were carried out in serum-free RPMI medium (1-41F24-I, Amimed), 
supplemented with 2 mM Glutamax (35050-038, Gibco), and 20 mM HEPES. The pH of all 
solutions was adjusted using a calibrated pH meter (Metrohm, Herisau, Switzerland) with 
NaOH or HCl, and the medium was equilibrated in a 5% CO2 incubator for 36 h. All data 
presented are referenced to pH measured at room temperature.  
Culture of cell lines 
The monocytic cell line MonoMac 6 (MM6, obtained from DMSZ) was cultured in RPMI 
(Sigma-Aldrich, Munich, Germany) supplemented with 10% FCS, 1% nonessential amino 
acids, and 1% oxalacetic acid–pyruvate–insulin medium supplement (Sigma-Aldrich), and 
maintained according to the American Type Culture Collection (ATCC). 
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Patient tissue samples 
Primary intact colonic epithelial cell crypts were isolated from normal human colonic 
tissue of patients undergoing bowel surgery as previously described.27 Biopsies of human 
terminal ileum, colon, or rectum were taken from patients with CD or UC, or from control 
subjects undergoing colonoscopy for colon cancer screening. Biopsies from patients with 
colitis were taken endoscopically from inflamed areas. Written consent was obtained 
before specimen collection and studies were approved by the local ethics committee.  
Isolation of human peripheral blood monocytes  
Normal human peripheral blood monocytes, obtained from the Swiss Red Cross Blood 
Service, were isolated from buffy coat samples, by density gradient centrifugation using 
Lymphoprep (Axis-Shield, Norway). Purification was performed using EasySep™ Human 
Monocyte Enrichment Kit without CD16 Depletion and EasySep magnet (both from 
Stemcell, Canada) according to manufacturer's instructions. The purity of the monocytes 
was > 85% as assessed by fluoroscein isothiocyanate (FITC)-labelled anti-CD14 
(#557742, BD Biosciences, USA) by flow cytometry (data not shown). 
Animal models 
All animal experiments were performed according to Swiss animal welfare laws and were 
approved by the Veterinary Authority of Basel-Stadt and the Veterinary Office of the 
Canton Zürich, Switzerland. Ogr1-/- (C57BL/6) mice, initially obtained from Deltagen, Inc. 
- San Mateo, Ca, USA, were generated as described.28 Il-10 -/- mice (C57BL/6) mice and 
Ogr1-/- mice were crossed to generate Ogr1 -/- /Il-10 -/- colitis susceptible mice. Mice were 
observed until reaching either 200 days of age or suffering a prolapse. All mice were 
housed together in one room in a vivarium. 
Genomic DNA extraction and genotyping  
Genotyping was confirmed by PCR of tail genomic DNA. DNA extraction was performed 
according to standard NaOH methods. The PCR reactions used for Ogr1 genotyping were 
performed as previously described28, oligonucleotides used are listed in the 
supplementary material and methods. 
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Murine macrophage isolation and culture  
Mature quiescent macrophages were isolated from the mouse peritoneal cavity without 
the aid of eliciting agents, as described by Zhang et al.29 Animals were sacrificed by 
cervical dislocation to reduce influence on pH. Further details are described in the 
supplementary methods. 
Evaluation of inflammation in murine colitis 
Typical inflammatory parameters were evaluated as previously described.30, 31 
Expression Profiling by Microarrays  
Global whole-transcript analysis was performed using a GeneAtlas microarray system 
(Affymetrix) to compare response differences between Ogr1+/+ and Ogr1-/- murine 
macrophages after 24 h acidic pH shift. Mature murine quiescent peritoneal macrophages 
were isolated as described above, from age matched female Ogr1 -/- and Ogr1 +/+ mice 
(C57BL/6). Five replicates or mice per condition were used, and ≈ 1 x 106 
macrophages/per mouse obtained. Cells were not pooled. Cells were treated with pH 6.7 
equilibrated medium to activate Ogr1, and pH 7.7 to serve as negative controls. Cells were 
collected, and RNA and cDNA samples prepared. Biotin-labelled cDNA samples were 
hybridized to GeneChip Mouse Gene 1.1ST Array Strip (Affymetrix, P/N 901628) 
following protocols provided by Affymetrix. Data was summarized on gene-level using 
RMA (Robust Multi-array Average). Data quality was assessed using the bioconductor/R 
package 'arrayQualityMetrics'32 and reproducibility was assessed using Pearson's 
correlation for all the filtered expression values and hierarchical clustering. For all 
pairwise comparisons, differentially expressed genes were selected using ≥2.0-fold-
change, P<0.05 significance, as determined using ANOVA (as implemented by the R 
package, Linear Models for Microarray Data, 'limma') and F-test for the complete 
experimental design. The results were analyzed by global ranked fold change and using 
Metacore software for pathway enrichment. 
Statistical Analysis  
For murine prolapse ratio comparison studies, statistical differences between genotypes 
were calculated by chi-square test with Fisher’s exact test (exact significance, two sided) 
and risk estimate test from contingency tables. The prolapse survival analysis was 
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performed using Kaplan-Meier survival analysis (log rank Mantel-Cox test) and estimated 
median survival time. Groups of data were compared using nonparametric Mann-Whitney 
U-test (mouse data) or Kruskal-Wallis one-way ANOVA followed by Dunn’s multiple-
comparison test (patient data). Data are presented as mean ± SEM for a series of n 
experiments. Probabilities (p, two tailed) of p < 0.05 were considered statistically 
significant. Monocyte/macrophage expression data were analyzed using a one-way 
analysis of variance (ANOVA) followed by the Tukey Post Hoc test. Throughout this 
manuscript, asterisks denote significant differences at *=p<0.05, **=p<0.01, ***=p<0.001. 
RESULTS 
OGR1 mRNA expression is increased in IBD patients  
OGR1 mRNA expression in isolated crypts and terminal ileum, colon, or rectum specimens 
from IBD patients and control subjects was confirmed by RT-qPCR. Ct values from the 
isolated crypts from 4 patients ranged from 27 to 30, indicating moderate expression of 
OGR1 in colonic epithelium (data not shown). Compared with normal control subjects, 
OGR1 expression increased 2.3 -fold (p<0.05) in UC patients (n=8) and 2.2 -fold (p<0.01) 
in CD patients (n=29) (Figure 1).  
OGR1 expression is regulated by TNF in myeloid cells 
A local decrease in pH usually occurs at inflammatory sites, and monocytes are rapidly 
recruited, followed by an increase in pro-inflammatory cytokines. MM6 cells were treated 
with IFN-γ, IL-1β, IL-6, TNF or TGF-β, which are known to initiate immune and 
inflammatory responses in the mucosa. Stimulation by TNF resulted in significant up-
regulation of OGR1 expression (≈4-5-fold p<0.001, Figure 2A-B).  No induction of OGR1 
occurred by IFN-γ, IL-1β, IL-6 or TGF-β at 6 h (Figure 2A-B)  or at 1 h, 5 h or 24 h (data not 
shown). A concentration-dependent (0, 2.5, 10, 25, 50, 100 ng/ml) induction of OGR1 
mRNA expression in MM6 cells by TNF was confirmed at 4 and 8 h (Figure 2C). Maximal 
OGR1 induction, after 8 h treatment was reached at TNF concentration 50 ng/ml (Figure 
2C). Induction of OGR1 expression in MM6 cells by TNF returned to basal levels after 48 h 
(Figure 2D).  
Treatment of MM6 cells with PMA, a known PKC activator but also commonly used to 
differentiate monocytes into macrophage-like cells33, led to increased OGR1 expression 
(14 -fold at 24 h, p< 0.001) (Figure 2E).  
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To confirm the relevance of our findings in MM6 cells, we tested OGR1 -induction by TNF 
and PMA in primary human monocytes and mouse peritoneal macrophages. 
Concentration-dependent TNF and PMA induction of OGR1 mRNA was confirmed in 
human monocytes (Figure 3A-B). Similarly TNF -mediated OGR1 induction was observed 
in mouse macrophages (Figure 4). The intensity of the response to TNF was comparable 
in MM6 cells and primary mouse macrophages (Figure 2C-D MM6; Figure 4). The 
induction time of primary human monocytes was considerably slower but of similar 
intensity. Similarly, primary human monocytes exhibited a slower induction and lower 
response to PMA compared to MM6 cells. No induction of the other pH-sensing GPCRs 
GPR4 and TDAG8, by any of the cytokines tested or by PMA was detected (data not shown).  
TNF, LPS or PMA induced OGR1 expression is reversed by Akt, MAP and PKC kinase 
and NF-κB inhibitors 
To understand the pathways involved in TNF, PMA or LPS-mediated induction of OGR1 
expression we investigated the roles of Akt1/2 kinase, c-Jun N-terminal kinase (JNK) and 
PKC by using their specific inhibitors. Mitogen-activated protein kinases (MAPKs) play an 
important role in regulating the cellular response to various extracellular stimuli.34 
Signaling via PKC is known to activate MAPKs.35 Activation occurs by sequential 
phosphorylation by JNK, ERK (extracellular-signal-regulated kinase) 1/2, p38 MAPK, 
ERK5 and ERK3/4.36 Activated MAPK kinase pathways may stimulate activator protein 1 
(AP-1).37,38 Exposure of monocytes and macrophages to TNF, LPS and PMA results in 
activation of the AP-1, NF-κB, caspase and MAPK pathways.39, 40  Akt is a serine-threonine 
kinase and has been implicated in TNF-mediated activation of NF-κB.41, 42  
Based on our time course experiments (Figure 2D), cells were stimulated with PMA, TNF 
or LPS, in the presence of the appropriate kinase inhibitor, A6730 (9 μM), SP600125 (20 
μM) and curcumin (25 μM), and harvested after 6 hours. 
Exposure of MM6 cells to PMA, TNF and LPS induced OGR1 expression 13.7, 8.2 and 10.3 
-fold respectively. The Akt1/2 kinase inhibitor, A6730, significantly decreased TNF and 
LPS -induced OGR1 expression, by 5.6 (68%) and 8.2 -fold (80%) respectively, but with 
less effect on PMA activation (4.8 -fold decrease, 35% decrease) (n=2, p<0.001 or 0.01, 
Figure 5A). SP600125, a JNK inhibitor, decreased OGR1 induction by PMA 10.1 -fold, 
(73%) TNF 4.0 -fold (48%) and LPS 7.5 -fold (80%). These results suggest that the 
JNK/AP1 pathway may be involved in OGR1 regulation. Curcumin is a potent inhibitor of 
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protein kinase C43 and inhibits NF-κB activation through inhibition of IκB kinase and Akt 
activation.44 Curcumin abolished the induction of all three activating agents (PMA 12.7 -
fold (93%), TNF 7.2 -fold 87% and LPS 9.9 -fold 96% decrease). These preliminary kinase 
inhibitor studies suggest that Akt1/2, JNK, PKC and IKK pathways play an important role 
in the induction of OGR1 expression by PMA, TNF and LPS.  
Prompted by the results we next tested a number of known NF-κB inhibitors. TNF-, PMA-
, or LPS-mediated induction of OGR1 was significantly reduced by simultaneous treatment 
of cells with NF-κB inhibitors: curcumin (25 μM), MG-132 (20 μM), AICAR (0.5 nM), BAY-
11-7082 (20 μM), CAY10512 (0.3 μM), and SC-514 (25 μM) (Figure 5A-C).  In the presence 
of the inhibitor MG132, TNF induced OGR1 expression decreased 3.2 and 5.7 -fold 
respectively (TNF 95% decrease, PMA 89% decrease) (n=2, p< 0.001, Figure 5B).  
AICAR (5-Aminoimidazole-4-carboxyamide) ribonucleoside blocks the expression of pro-
inflammatory cytokines genes by a reduction in NF-κB DNA-binding activity45. BAY-11-
7082 and SC-514 block NF-kB activation by inhibition of IκB kinase.46, 47 The resveratrol 
analog CAY10512 is a specific NF-κB inhibitor. Treatment with PMA, TNF or LPS resulted 
in 10.2, 3.0 or 7.6 -fold increase in OGR1 expression respectively, but in the presence of 
the NF-κB inhibitors induction of OGR1 significantly decreased. OGR1 expression 
decreased with inhibitor; AICAR 9.3-, 2.6- and 7.3 -fold / (91%, 88%, 96%) ; BAY 7082, 
9.0-, 2.6- and 6.1 -fold / (88%, 87%, 81%); Cay 10512, 5.6-, 1.8- and 3.8 -fold / (56%, 62%, 
49%), ; SC-514, 8.7-, 2.7- and 7.4 -fold (85%, 91%, 97%) on PMA, TNF and LPS stimulation, 
respectively (Figure 5C). The results collectively suggest that NF-κB plays a key role in the 
regulation of OGR1. 
In silico analysis of the OGR1 promoter 
As the inhibitor studies suggested a strong role for AP-148 and NF-κB in the regulation of 
OGR1 expression we next performed an in silico promoter analysis of OGR1. Two 
alternative predicted promoter variants ≈ 9 kpb apart, exist for the OGR1 gene on 
chromosome 14. In silico analysis using MatInspector software49 
(http://www.genomatix.de/matinspector.html) revealed several putative DNA-binding 
sites for AP-1, NF-κB and HIF-1α within the proximal regions of the OGR1 promoter 
variants. A schematic representation of these sites (TBSs) for OGR1 variants 1 and 2 and 
binding sites are shown in Supplemental Figure S1 and S2, respectively. 
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Cellular responses upon OGR1 activation by extracellular acidification in murine 
macrophages. 
We further investigated the effect of OGR1 deficiency on intestinal inflammation. We 
conducted a microarray study and compared the global gene expression of wild type 
Ogr1+/+ cells to Ogr1-/- cells in response to extracellular acidification. We selected the top 
100 most differentially expressed genes by comparing the ranked fold change upon pH 
shift in WT compared to KO macrophages. Figure 6A shows a heat map summarizing gene 
expression across all samples in the 4 experimental conditions for these 100 genes. 
Acid-induced OGR1-mediated differentially up-regulated genes in WT macrophages 
compared to OGR1 KO macrophages include inflammatory response genes (Tnfrsf13c, 
Ccl24, Cxcl13, C1qa, Nr4a1) and immune response genes (Iglv1, Cd79a, H2-Eb1, Tinagl1, 
Lst1, C1qa, C1qb Cd83, Ccl17). Furthermore, genes associated with adhesion and ECM 
(Sparc, Cyr61, Timp1, Aebp1, Ebp1, Siglec1, Cdh2, Mmp11, Serpine2, Tgm2), and actin 
cytoskeleton (Inhba, Fscn1, Sorbs2, Tuba1c, Map1b, Parva, Cnn3) were up-regulated by 
acidic activation of OGR1 in WT but not in OGR1 KO macrophages. Interestingly, 
cholesterol homeostasis genes, (Cyp11a1, Ephx2), glucose response and insulin 
processing genes, (Inhba, Cpe, Cma1, Igfbp7, Htra1, Sfrp4), differentiation and bone 
development gene Bmp-2 and transcription factor gene Nrbf2 also increased in WT 
Ogr1+/+ compared to Ogr1-/- KO cells at acidic pH.  
The scatter plot represents the ratio fold change low to high pH OGR1 KO /fold change low 
to high pH WT macrophages (Figure 6B). The top 100 differentially expressed genes are 
shown in Supplementary Tables S2.A–B. In addition, a list of genes and enrichment 
pathways, generated in GeneGo by comparison of pairs of WT low pH vs. high pH to OGR1 
KO low pH vs. high pH, is shown in supplementary Table S3 and Figure S3 respectively. 
Results discussed in this paper have been deposited in the NCBI Gene Expression Omnibus 
(GEO) Accession No. GSE60295 (http://www.ncbi.nlm.nih.gov/projects/geo). 
OGR1 deficiency protects from development of spontaneous colitis in mice 
To investigate whether the OGR1 dependent changes upon acidification have functional 
consequences during IBD, we applied a mouse model of spontaneous colitis. Analysis of 
the occurrence of prolapse in the colon over the course of 200 days showed that, only 
16.7% of female Ogr1-/-/Il-10-/- mice (n=24) developed rectal prolapse. The incidence was 
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significantly lower than that of female Ogr1+/+/Il-10-/- littermate mice (66.7%, n=12) 
maintained in the same vivarium room during the same time period (p = 0.007**; Odds 
Ratio for female mice Ogr1 -/-/Ogr1+/+ = 0.100 (95% CL 0.020~0.500), chi-square test with 
Fisher’s exact test with two sides). Kaplan‐Meier survival analysis showed a significantly 
delayed onset and progression of rectal prolapse in female Ogr1-/-/Il-10-/- mice (estimated 
median survival time: >200 days vs. 123 days for female Ogr1+/+/Il-10-/- mice, p=0.002 **, 
log rank (Mantel‐Cox) test) (Figure 7). No prolapses were observed in control Ogr1+/+/Il-
10+/+ mice (n > 100 animals). 
Histologically, consistent with the prolapse ratios, Ogr1-/-/Il-10-/- mice showed less 
inflammation (score 3.7±1.03) (Figure 8A), however, this difference did not reach 
statistical significance from Ogr1+/+/ll-10 -/- female mice (6.5±1.12) (p>0.05, Figure 8B).  
The same trend in MPO levels of female Ogr1 -/-/Il10-/- mice was observed (0.12±0.034 vs. 
0.41±0.072, p>0.05, Figure 9A). There were no differences in colon length, relative spleen 
weight (Figure 9B-C) and in cytokines mRNA expression levels (Figure 10). 
Discussion   
Our manuscript provides evidence for a role of the pH-sensing receptor OGR1, in 
inflammatory processes such as intestinal inflammation. We show that OGR1 mRNA 
expression is up-regulated ≈ 2 -fold during intestinal inflammation in IBD patients. To 
what extent this translates into up-regulated protein expression cannot currently be 
assessed due to a lack of suitable antibodies. We further show that the pro-inflammatory 
cytokine TNF, a major mediator in IBD associated inflammation induces OGR1 expression 
in human and murine myeloid cells. TNF up-regulates OGR1 expression for short periods 
(6 to 12 h), however, the effect is not sustained for longer periods, after 24 - 48 h OGR1 
expression returns to basal levels.  
Similar to our findings, Lum and coworkers reported that expression of GPR4, a related 
proton sensing GPCR, is up-regulated several-fold by TNF and H2O2 in human brain 
microvascular endothelial cells.50 TNF-mediated induction of GPR4 occurred after 2 h and 
was sustained for 24 h.50 However, in contrast to OGR1, we did not observe induction of 
GPR4 and TDAG8 expression upon treatment with TNF, PMA, or LPS in MM6 cells. OGR1 
expression induced by TNF, PMA or LPS was prevented by treatment with PI-3 (Akt1/2), 
MAP and PKC inhibitors and with NF-κB inhibitors AICAR, BAY-11-7082, CAY10512, and 
SC-514. LPS stimulates production of TNF in MM6 cells.51, 52 
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We further show that genetic deletion of OGR1 ameliorates inflammation at least in female 
mice. Acidification and signaling via OGR1 induced a multitude of cellular responses in the 
microarray analysis. In murine macrophages acid induced OGR1-mediated enriched up-
regulated genes are involved in inflammatory responses, further supporting our finding 
that OGR1 signaling upon pH changes may play an important role in mucosal 
inflammation. Notably, up-regulation of nuclear receptor subfamily 4 group A member 1 
(NR4A1, also known as NUR77) was detected (Supplementary Table S3). NR4A1 functions 
as an immediate early-response gene and plays a key role in 
mediating inflammatory responses in macrophages.53 Further affected pathways are actin 
cytoskeleton modulation and cell adhesion. This may also be relevant as anti-adhesion 
strategies for the treatment of IBD have been recently successful and vedolizumab as an 
antibody against α4β7 integrin recently has been approved for therapy of Crohn’s disease 
by the FDA and EMA. In an OGR1-overexpressing Caco2 model we also observed 
enrichment of inflammatory response, including NR4A1, actin cytoskeleton, and adhesion 
and ECM genes upon acidification (manuscript in submission). In the present study, the 
genes Inhba and Nr4a1 which are linked to the myocardin-related transcription factor 
(MRTF) pathway54, were also found to be strongly regulated by pH change. 
Another strongly regulated gene was activin. Activin A is released early in the cascade of 
circulatory cytokines during systemic inflammatory episodes, roughly coincident with 
TNF and before IL-6 and follistatin are elicited. Activin A protein is also elevated in IBD 
patients and in experimental colitis.55 Recently activin A was identified to regulate 
macrophage switch between polarization states.56 This skew towards a pro-inflammatory 
phenotype occurs by promoting the expression of M1 (GM-CSF) markers, and impairing 
the acquisition of M2 (M-CSF) markers, while down-regulating the production of Il-10.56 
Furthermore, SPARC (Secreted protein acidic and rich in cysteine) was found to be 
strongly regulated by OGR1. SPARC is a gene whose methylation has been related to IBD.57, 
58 SPARC exacerbates colonic inflammatory symptoms in DSS-induced murine colitis. 
Compared to WT, SPARC KO mice had less inflammation with fewer inflammatory cells 
and more regulatory T cells.59 
Why would pH-sensing be so important during intestinal inflammation? Firstly, pH 
homeostasis is important for the maintenance of normal cell function. pH is normally 
tightly controlled within a narrow range. Normal pH of blood and tissue is controlled at ≈ 
pH 7.2- 7.4. Maintaining homeostasis requires cells to sense their external environment, 
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communicate with each other, and respond rapidly to extracellular signals. This can be 
achieved by hydrophobic molecules, ion channels, catalytic receptor and G-protein-
coupled receptors.60 
Under physiological conditions there are also counterplayers of OGR1 expressed in the 
mucosal tissue. TDAG8 mediates extracellular proton-induced inhibition of 
proinflammatory cytokine production in mouse macrophages.2 Onozawa et al. showed 
that TDAG8 deficient mice exhibit enhanced arthritic symptoms compared to wild type 
animals; suggesting that TDAG8 attenuates inflammation by negatively regulating the 
function of the macrophages, T cells and B cells.23 In search for genetic components and 
causal genetic variants of IBD, genome-wide association (GWA) studies have identified 
numerous susceptibility regions that are marked by single nucleotide polymorphisms 
(SNPs).22, 61, 62 Association results and in silico analysis identified a locus within the TDAG8 
gene as susceptibility locus in CD22, supporting that TDAG8 acts as a negative regulator of 
inflammation. Khor et al. propose that the presence of TDAG8 as an IBD-risk loci is 
necessary to maintain intestinal homeostasis due to its immune modulatory effect.63 
To summarize, ORG1 expression is induced in human and murine myeloid cells by TNF, 
PMA and LPS; whereby simultaneous treatment with NF-κB inhibitors caused a reversal 
of this effect. Up-regulated genes induced by extracellular low pH by proton-sensing OGR1 
IN murine macrophages were enriched for inflammatory and immune response, actin 
cytoskeleton and cell adhesion genes sets. The deficiency of pH-sensing receptor OGR1 
protects from spontaneous inflammation in the Il-10 KO model. Thus, pH sensors may be 
interesting new targets for pharmacological intervention in intestinal inflammation. 
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FIGURE AND TABLE LEGENDS  
Figure 1. OGR1 expression in human intestinal mucosa 
IBD patients expressed higher levels of OGR1 mRNA in the mucosa as compared to 
controls. Expression levels normalized to GAPDH. Biopsy specimens were taken from 29 
CD patients, 8 UC patients and 17 non-IBD control patients. Asterisks denote significant 
differences from the respective control (*P < 0.05, **P < 0.01, ***P <0 .001). 
Figure 2. TNF and PMA induce OGR1 expression in human monocytes 
A – B. MonoMac6 (MM6) cells were treated with cytokines for 6 hours. Treatment of MM6 
cells with TNF led to significant up-regulation of OGR1. No induction of OGR1 occurred 
with other cytokines (IFN-γ, IL-1β, IL-6, TGF-β) (50 ng/ml) tested. C. Concentration-
dependent TNF (0, 2.5, 10, 25, 50, 100 ng/ml) induction of OGR1 mRNA expression was 
confirmed at 4 and 8 h. Maximal OGR1 induction was reached at TNF concentration 50 
ng/ml at 8 h.  D. Induction of OGR1 expression by TNF (50 ng/ml) returned to basal levels 
after 48 h. E.  Monocytic-macrophagic differentiation of MM6 cells with phorbol 12-
myristate 13-acetate (PMA) (25 nM), a specific activator of protein kinase C (PKC) and NF-
κB, led to a significant increase in OGR1 mRNA expression. Asterisks denote significant 
differences from the respective control (*P < 0.05, **P < 0.01, ***P <0 .001). 
Representative data of one of three qualitatively similar experiments shown unless 
indicated.  
Figure 3. TNF- and PMA-dependent induction of OGR1 mRNA in primary human 
monocytes. A. Dose-dependence of TNF (0, 2.5, 10, 25, 50 ng/ml) induction of OGR1 
mRNA was confirmed in primary human monocytes. B. PMA (0, 5, 25, 50, 75, 100 ng/ml) 
induction of OGR1 mRNA was confirmed in primary human monocytes. Asterisks denote 
significant differences from the respective control (*P < 0.05, **P < 0.01, ***P <0 .001). 
Representative data of one of two similar experiments shown.  
Figure 4. TNF induces OGR1 expression in murine macrophages. OGR1 induction by 
TNF (25 ng/ml) was also confirmed in primary mouse residential peritoneal 
macrophages. Asterisks denote significant differences from the respective control (*P < 
0.05, **P < 0.01, ***P <0 .001). Representative data of one of three similar experiments 
shown.  
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Figure 5. TNF-, PMA-, and LPS-mediated induction of OGR1 in MM6 cells was 
reversed by simultaneous treatment of cells with kinase and NF-kB inhibitors. A. 
Kinase inhibitors, A6730 (9 μM), SP600125 (20 μM) and curcumin (25 μM), reduced or 
abolished TNF (25 ng/ml), PMA (25 nM), or LPS (1 μg/ml) mediated induction of OGR1 in 
MM6 cells.  B. Treatment with NF-kB inhibitor MG-132 (20 μM) significantly reduced TNF 
(50 ng/ml) or PMA (25 nM) mediated induction of OGR1 in MM6 cells. C. AICAR (0.5 nM), 
BAY-11-7082 (20 μM), CAY10512 (0.3 μM), and SC-514 (25 μM) also reduced TNF (25 
ng/ml), PMA (25 nM), or LPS (1 μg/ml) mediated induction of OGR1. Asterisks denote 
significant differences from the respective control (*P < 0.05, **P < 0.01, ***P <0 .001). 
Representative data of one of two similar experiments shown. 
Figure 6. Global gene expression of acid response of mouse macrophages. A. Top 100 
genes from the whole-transcript microarray analysis of acid response (pH 6.7) of wild 
type (WT) and Ogr1 KO murine macrophages. Control condition, pH 7.7 is shown on the 
left. Changes in gene expression within each comparison are represented as Log2-
transformed fold changes (≥2.0-absolute-fold-change, P<0.05 significance). B. 
Differentially expressed genes for acid response in WT and OGR1 KO macrophages. Fold 
changes in low to high pH shift of OGR1 KO macrophages are depicted on y-axis and fold 
changes low to high pH WT macrophages are shown on the x-axis. The highest ranking 
differentially expressed genes in the acid response of WT mouse macrophages are shown 
in the lower right quadrant of the scatter plot and the upper left quadrant shows the 
highest ranking differentially expressed genes in the acid response of OGR1 KO mouse 
macrophages.  
Figure 7. OGR1 deficient mice show delayed onset and severity of prolapse in a 
spontaneous IL-10 knock out mouse model. Kaplan‐Meier survival analysis showed a 
significantly delayed onset and progression of rectal prolapse in female Ogr1 -/-/Il-10-/- 
mice (estimated median survival time: >200 days vs. 123 days, p=0.002 **, log rank 
(Mantel‐Cox) test). Green solid lines, Ogr1 -/-/Il-10 -/- mice (16.7% prolapses, n=24); blue 
solid line, Ogr1 +/+/Il-10 -/- mice (66.7% prolapses, n=12); grey solid lines, Ogr1+/+/Il-10+/+ 
mice (0% prolapses, n=31). No rectal prolapses were detected in any of the Ogr1+/+/Il-
10+/+ mice in the breeding colony in the study, 200 days.  
Figure 8. OGR1 deficient mice exhibit a trend to less inflammation in a spontaneous 
IL-10 knock out mouse model  A. Microscopic analysis of terminal colon sections from 
Ogr1 -/-/Il-10 -/-, Ogr1+/+/Il-10-/- and Ogr1+/+/Il-10+/+ 80-day-old mice, staining by 
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Hematoxylin and eosin. Representative images are shown. B. Histological score, based on 
evaluation of morphological changes of epithelium and immune cell infiltration, of distal 
colon from Ogr1 -/-/Il-10 -/-, Ogr1+/+/Il-10 -/- and Ogr1+/+/Il-10+/+ 80-day-old mice. Data 
presented as mean ± SEM; n ≥ 5 per group; Asterisks denote significant differences from 
the respective control (*P < 0.05, **P < 0.01, ***P <0 .001). All mice were female. 
Figure 9. The development of IBD and progression of prolapse between Ogr1 -/-/IL-
10 -/-and Ogr1+/+/Il-10-/- female mice. A. Comparison of MPO activity in colon tissue B. 
Assessment of colon length. C. Relative spleen weight. No significant differences in OGR1 
KO/Il-10 KO mice and controls in these parameters were observed. 
Figure 10.  Expression levels of cytokines in colons of female Ogr1 -/-/Il-10 -/- , Ogr1 +/+/Il-
10 -/- and Ogr1 +/+/Il-10+/+ (WT control) mice were determined by real-time PCR and 
normalized to GAPDH. (n= 6~9 mice per group). The homogenate of each mouse colon 
sample was tested in triplicate. Data presented as mean ± SEM; Asterisks denote 
significant differences from the respective control (*P < 0.05, **P < 0.01, ***P <0 .001). No 
statistical difference between colon and mesenteric lymph nodes of female Ogr1 -/-/Il-10-
/- mice and female Ogr1 +/+/Il-10 -/- mice was observed (p>0.05, Kruskal-Wallis one-way 
ANOVA followed by Dunn’s multiple-comparison test).  
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Supplementary Material 
The G protein-coupled pH-sensing receptor OGR1 is a regulator of 
intestinal inflammation 
 
 
Materials and Methods 
Chemicals  
Cytokines were obtained from Sigma-Aldrich (St. Louis, MA, USA), unless otherwise 
stated. TNF (#654205) was purchased from Calbiochem (Merck Darmstadt, Germany). 5-
aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) (#100102-41), BAY-
11-7082 (#100010266), CAY10512 (#10009536), Curcumin (#81025.1), SC-514 
(Cayman#10010267), SP600125 (Cayman #100010466) were purchased from Cayman 
(Ann Arbor, Michigan, USA).  
Genomic DNA extraction and genotyping  
For PCR reactions, the oligonucleotides used were as follows:  
Il-10 genotyping: 5’-GTGGGTGCAGTTATTGTCTTCCCG-3’ (oIMR0086),  
5’-GCCTTCAGTATAAAAGGGGGACC-3’ (oIMR0087),  
5’-CCTGCGTGCAATCCATCTTG-3’ (oIMR0088),  
Ogr-1 genotyping:  
5’-ACCACC AGTGATGCCTAGATCCTG A-3’ (P416),  
5’-AAGATGACCACGGTGCTGAGC ACC A-3’ (P417),  
5’-CCATTCGACCACCAAGCG AAACAT C-3’ (R3).  
 
Murine macrophage isolation and culture  
Peritoneal murine macrophages were centrifuged, washed in PBS and resuspended in 
RPMI 1640 medium containing 2 mM Glutamax (35050-038, Gibco), 10% fetal calf serum 
(2-01F120-I, Amimed, Bio Concept, Allschwil, Switzerland), 100 U/ml penicillin, 100 
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µg/ml streptomycin (all obtained from Sigma–Aldrich, Buchs, Switzerland). Cells from 
each mouse were treated without pooling, after plating in 6 well plates (≈ 3 x 106 cells in 
1 ml/well) at 37°C, 5% CO2. After 2 h, non-adherent cells were removed. Macrophages 
were maintained in RPMI medium, 5% CO2 for 24 h. Final number of cells per treatment 
(obtained from each mouse) was ≈ 1 x 106 cells.  The resulting adherent population 
consisted of ≈ 88% peritoneal macrophages as determined by flow cytometry (data not 
shown). 
RNA extraction and quantitative Real-Time RT-PCR.  
Human and mouse tissue.  
Tissue pieces used for RNA analysis were transferred immediately into RNAlater solution 
(Qiagen, Valencia, CA) and stored at −80°C. Tissue biopsies were disrupted in RLT buffer 
(Qiagen) using a 26G needle.  
Cells and tissue samples. Total RNA was isolated using the RNeasy Mini Kit in the 
automated QIAcube following the manufacturer’s recommendations (Qiagen, 
Hombrechtikon, Switzerland). For removal of residual DNA, DNase treatment, 15 min at 
room temperature, was integrated into the QIAcube program according to the 
manufacturer’s instructions. For cDNA synthesis, the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Foster City, CA), was used, following the 
manufacturer’s instructions. Determination of mRNA expression was performed by 
quantitative real-time PCR (qRT-PCR) on a 7900HT real-time PCR system (Applied 
Biosystems, Foster City, USA), under the following cycling conditions: 20 sec at 95 °C, then 
45 cycles of 95 °C for 3 sec and 60 °C for 30 sec with the TaqMan Fast Universal Mastermix. 
Samples were analyzed as triplicates. Relative mRNA expression was determined the by 
the comparative ∆∆Ct method1, which calculates the quantity of the target sequences 
relative to the endogenous control and a reference sample.  TAQMAN Gene Expression 
Assays, (all from Applied Biosystems, Foster City, USA), used in this study are listed in the 
online supplementary Table S1. 
 
 
 
Manuscript I 
79 
Table S1. TaqMan assays 
Gene 
Symbol 
Gene Name Assay ID 
GPR68  Human G protein-coupled receptor 68, OGR1 Hs 00268858- s1 
GPR4 Human G protein-coupled receptor 4 Hs 00270999 - s1 
GPR65  Human G protein-coupled receptor 65, TDAG8 Hs 00269247 - s1 
GAPDH 
Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
Endogenous Control  
4326317E 
ACTB Human ACTB (beta actin) Endogenous Control 4310881E 
HuPo  Human acidic ribosomal protein (RPLPO) Endogenous Control 4310879E 
HPRT1 Human Hypoxanthine guanine phosphoribosyl transferase 1 Hs01003268_g1 
GPR68 Mouse G protein-coupled receptor 68, OGR1 Mm00558545_s1 
GPR4 Mouse G protein-coupled receptor 4 Mm00558777_s1  
GPR65 Mouse G protein-coupled receptor 65, TDAG8 Mm00433695_m1  
CCL20 Mouse chemokine (C-C motif) ligand 20 Mm01268754_m1 
COX-2 Mouse prostaglandin-endoperoxide synthase 2 Mm00478374_m1 
CXCL1 Mouse chemokine (C-X-C motif) ligand 1 Mm04207460_m1 
CXCL2 Mouse chemokine (C-X-C motif) ligand 2 Mm00436450_m1 
IFN-γ Mouse interferon gamma Mm00801778_m1 
IL-18 Mouse Interleukin 18 Mm00434225_m1 
IL-6 Mouse Interleukin 6 Mm00446190_m1 
iNOS Mouse nitric oxide synthase 2 Mm01309893_m1 
MCP-1 Mouse chemokine (C-C motif) ligand 2 Mm00441242_m1 
SELE Mouse selectin, endothelial cell Mm00441278_m1 
TNF-α Mouse tumour necrosis factor alpha Mm99999068_m1 
VCAM1 Mouse vascular cell adhesion molecule 1 Mm01320970_m1 
GAPDH 
Mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
Endogenous Control  
Mm03302249_g1 
 
Human β-actin 4310881E, Human hupo, 4310879E, Human GAPDH 4326317E, Human HPRT1 
(hypoxanthine phosphoribosyltransferase 1) Hs01003268_g1 Cat. # 4331182  
Human HuPo/ RPLP0 (large ribosomal protein) Endogenous Control (VIC / TAMRA Probe, Primer Limited), 
4310879E, Human acidic ribosomal protein (HuPO), Hypoxanthine guanine phosphoribosyl transferase 
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Predictive location of OGR1 Promoter Variants 1 and 2 on Chromosome 14 
Human G protein-coupled receptor 68 (GPR68), transcript variant 1, mRNA 2,880 bp linear mRNA 
Human G protein-coupled receptor 68 (GPR68), transcript variant 2, mRNA 2,834 bp linear mRNA 
 VARIANT 2 
Exon 1   
(Non-coding exon) 
72720059…..72720224 
VARIANT 1 and VARIANT 2 
Exon 2 (coding exon) 
72698876 ….72701523  
NOTE: both variants have the 
same coding sequence 
72700297….72701394 
VARIANT 1 
Exon 1   
(Non-coding exon) 
72710641…..72710852  
Figure S1. Schematic representation of the in silico-
predictions of the DNA binding sites for the 
transcription factors AP-1, HIF-1α, and NF-κB within 
the proximal regions of the OGR1 promoter variants 
1 and 2. The arrow indicates the transcription start 
site. Numbers above the boxes indicate the distance 
from the transcription start site. Numbers in red 
indicate identity of the consensus binding motive. 
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Figure S2. List of possible binding sites to the consensus elements AP-1, HIF1-α and 
NFκB in the in silico promoter analysis of OGR1. 
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Figure S3. Enrichment analysis: Meta Core (Gene Go) Pathway Maps Ontology. Pairwise 
comparison of acidified WT vs. Ogr1 KO murine macrophages. pH 6.7 24 h. Extracellular 
acidosis activation of Ogr1 in murine macrophages show that the most significantly 
enriched canonical pathways include Activin A associated pathways, immune response 
and actin cytoskeleton remodeling pathways. 
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Rank 
WT/KO 
Ratio 
Symbol Full name Involved in: 
(Reference: Gene Card, NCBI, JAX, Uniprot, 
unless otherwise indicated) 
1.  Cyp11a1 Cholesterol side chain cleavage 
enzyme, mitochondrial (Cytochrome 
P450 11A1) 
Cholesterol, lipid or steroid metabolism. 
Catalyses the side-chain cleavage reaction of 
cholesterol to pregnenolone.  
2.  Sparc Secreted acidic cysteine rich 
glycoprotein (Osteonectin, Basement 
membrane protein 40 (BM-40)) 
Cell adhesion, wound healing, ECM 
interactions, bone mineralization. Activates 
production and activity of matrix 
metalloproteinases. 
3.  Tpsb2 Tryptase beta-2 or tryptase II  (trypsin-
like serine protease)  
Inflammatory response, proteolysis. 
4.  Inhba Inhibin Beta A or Activin beta-A chain Immune response and mediators of 
inflammation and tissue repair.2-5 
5.  Cpe Carboxypeptidase E Insulin processing, proteolysis.  
6.  Igfbp7 Insulin-like growth factor-binding 
protein 7 
Stimulates prostacyclin (PGI2) production and 
cell adhesion. Induced by retinoic acid. 
7.  Clu Clusterin Chaperone-mediated protein folding, positive 
regulation of NF-κB transcription factor 
activity. Protects cells against apoptosis and 
cytolysis by complement. Promotes 
proteasomal degradation of COMMD1 and 
IKBKB.  
8.  Cma1 Chymase 1 Cellular response to glucose stimulus, 
interleukin-1 beta biosynthetic process. 
Possible roles: vasoactive peptide generation, 
extracellular matrix degradation. 
9.  Sfrp4 Secreted frizzled-related protein 4 Negative regulation of Wnt signalling. 
Increases apoptosis during ovulation. 
Phosphaturic effects by specifically inhibiting 
sodium-dependent phosphate uptake.  
10.  Ephx2 Bifunctional epoxide hydrolase  Cholesterol homeostasis, xenobiotic 
metabolism by degrading potentially toxic 
epoxides.  
11.  Pcolce Procollagen C-endopeptidase enhancer Proteolysis. Collagen binding. Component in 
collagen and extracellular matrix. 
12.  Akr1cl Aldo-keto reductase family 1, member 
C-like 
Oxidoreductase activity 
13.  Cyr61 Cysteine rich protein 61 Cell adhesion, chemotaxis, cell proliferation, 
wound healing and angiogenesis. 
14.  Sfrp2 Secreted frizzled-related protein 2 Differentiation, modulator of Wnt signalling 
pathway.  
15.  Parm1 Prostate androgen-regulated mucin-
like protein 1 
Regulation of TLP1 expression and telomerase 
activity, enabling certain prostatic cells to 
resist apoptosis.  
16.  Bcat1 Branched chain aminotransferase 1 Branched-chain amino acid biosynthetic 
process. 
 
17.  Mgarp Mitochondria localized glutamic acid 
rich protein, Hypoxia up-regulated 
mitochondrial movement regulator 
protein 
Response to steroid hormone stimulus & 
hypoxia. Trafficking of mitochondria along 
microtubules. Aids steroidogenesis through 
maintenance of mitochondrial abundance & 
morphology. 
Table S2.A-B. Differentially expressed genes following activation of OGR1 by acidic pH in mouse 
peritoneal macrophages pH 6.7 24 h.  A.  Gene List, including gene process B. Complete Table (Excel). 
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18.  Ppic Peptidyl-prolyl cis-trans isomerase C, 
cyclophilin C, cyp-20c 
Accelerates protein folding.  
 
19.  Aldh1a1 Retinal dehydrogenase 1, aldehyde 
dehydrogenase family 1, A1 
9-cis-retinoic acid biosynthetic process. 
Converts/oxidizes retinaldehyde to retinoic 
acid. 
20.  9930013L
23RikCemi
p 
Cell migration inducing protein ER retention sequence binding, hyaluronic acid 
binding,  
21.  Fscn1 Fascin homolog 1, actin bundling 
protein 
Actin filament bundle assembly, cell migration. 
Organization of actin filament bundles, 
formation of microspikes, membrane ruffles, 
and stress fibres. Associates with beta-catenin. 
22.  Sorbs2 Sorbin and SH3 domain containing 2 Actin filament organization, cell adhesion, cell 
migration.   
23.  Tuba1c Tubulin, alpha 1C Microtubule-based process.  
24.  Leprel1 Prolyl 3-hydroxylase 2 leprecan-like 
protein 1 
Collagen metabolic process, negative 
regulation of cell proliferation.  
25.  Prss35 Inactive serine protease 35 Serine protease homolog.  
26.  Plscr2 Phospholipid scramblase 2 Cellular response to lipopolysaccharide.  
27.  Ccnd2 Cyclin D2 Cell cycle, cell division, protein kinase binding. 
28.  Serpinh1 Serpin H1  Stress response. Binds specifically to collagen. 
May be involved as a chaperone in the 
biosynthetic pathway of collagen.  
29.  Iglv1 Immunoglobulin lambda variable 1 Immune Response 
30.  Tnfrsf13c Tumour necrosis factor receptor 
superfamily, member 13c 
B, T cell costimulation, positive regulation of B 
and T cell proliferation, positive regulation of 
interferon-gamma biosynthetic process. 
31.  Timp1 Metalloproteinase inhibitor 1,  tissue 
inhibitor of metallo-proteinase 1 
Response to cytokine, negative regulation of 
apoptotic process, wound healing. Complexes 
with metalloproteinases (such as collagenases) 
and irreversibly inactivates them by binding to 
their catalytic zinc cofactor. 
32.  Rpl18a Ribosomal protein L18A Translation 
33.  Cd79a CD79A antigen (immunoglobulin-
associated alpha) 
Immune response 
34.  Ccl24 Chemokine (C-C motif) ligand 24 Chemotaxis, Inflammatory response, 
cytoskeleton organization 
35.  Nrbf2 Nuclear receptor (NR) binding factor 2 Transcription, transcription regulation. May 
modulate transcriptional activation by target 
NRs. 
36.  Gm9513 Predicted gene 9513, Secreted tfp/ly-
6/upar protein pate-p 
N/A 
37.  Rpl35a Ribosomal protein L35A rRNA processing  
38.  1700022K
RikN4bp2
os 
NEDD4 binding protein 2, opposite 
strand 
N/A 
39.  H2-Eb1 Histocompatibility 2, class II antigen E 
beta 
Antigen processing and presentation of 
exogenous peptide antigen via MHC class II.  
40.  Map1b Microtubule-associated protein 1B Microtubule bundle formation, actin binding, 
cytoskeletal regulatory protein binding. 
41.  Nrn1 Neuritin 1 Axonogenesis  
42.  Tinagl1 Tubulointerstitial nephritis antigen-like 
1 
Immune response, proteolysis, cysteine-type 
peptidase activity, laminin binding. 
43.  Gm11937 Predicted gene 11937 Fibrous proteins rich in cysteine, keratin. 
44.  Olfr1004p
s1 
Olfactory receptor 1004, pseudogene 1 Olfactory receptor  
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45.  Cxcl13 Chemokine (C-X-C motif) ligand 13 Chemotaxis, Inflammatory response.  
46.  Htra1 Htra serine peptidase 1 or insulin-like 
growth factor binding protein 5 
protease 
 
 
Negative regulation of defense response to 
virus, TGFβ receptor and BMP signalling 
pathway 
47.  Parva Parvin, alpha Actin cytoskeleton reorganization, actin-
mediated cell contraction, cell polarity, 
substrate adhesion-dependent cell spreading, 
directed cell migration. 
 
48.  Aebp1 AE binding protein 1, Adipocyte 
enhancer-binding protein 1 
Cell adhesion, proteolysis. Isoform 2 may 
positively regulate NF-κB activity in 
macrophages by promoting phosphorylation 
and degradation of  
Iκ-B-α (NFKBIA), leading to enhanced 
macrophage inflammatory responsiveness. 
49.  Lst1 Leukocyte specific transcript 1 Cell shape, immune response. Induces 
filopodia and microspikes, may be involved in 
dendritic cell maturation 
50.  Psmb5-ps Proteasome (prosome, macropain) 
subunit, beta type 5, pseudogene 
Proteasome-mediated ubiquitin-dependent 
protein catabolic process, response to 
oxidative stress. 
51.  Trav13-2 T cell receptor alpha variable 13-2  
52.  Krtap6-2 Keratin associated protein 6-2 Hair keratin-associated protein gene 
53.  Kcng2 Potassium voltage-gated channel, 
subfamily G, member 2 
Potassium ion transmembrane transport 
54.  Dab2 Disabled 2, mitogen-responsive 
phosphoprotein 
Apoptosis, Differentiation, Endocytosis, 
Protein transport, Transport, Wnt signalling.  
55.  Atp2a3 Endoplasmic reticulum (ER)  
Ca2+ ATPase 3  
Ca2+ transport, ion transport. Mg2+-dependent 
enzyme, catalyses hydrolysis of ATP coupled 
with transport of Ca2+. Transports Ca2+ from 
cytosol into  sarcoplasmic/ER lumen 
56.  Siglec1 Sialic acid binding Ig-like lectin 1, 
sialoadhesin 
Cell adhesion, endocytosis 
57.  Gm6816 
(Rps4lps) 
Ribosomal protein S4-like, pseudogene Translation 
58.  Mmp11 Matrix metallopeptidase 11 Basement membrane organization, Ca2 
binding, metalloendopeptidase activity, Zn2+- 
binding 
59.  Fdx1 Ferredoxin 1 Cholesterol metabolic process, hormone 
biosynthetic process 
60.  Adamts1 ADAM metallopeptidase with 
thrombospondin type 1 motif, 1 
Inflammatory response  
61.  Fbxo32 F-box protein 32 Protein ubiquitination  
62.  Uck2 Uridine-cytidine kinase 2 UMP, CTP salvage, cellular response to oxygen 
levels.  
63.  Tm4sf19 Transmembrane 4 L six family member 
19 
N/A 
64.  Gm10334 Predicted gene 10334 Proteolysis 
65.  Rps2-ps13 Ribosomal protein S2, pseudogene 13 N/A  
66.  Slc16a2 Solute carrier family 16 
(monocarboxylic acid transporters), 
member 2 
Symporter activity 
67.  Cdh2 Cadherin-2 Cell adhesion, calcium-dependent. 
68.  Gm13375 Predicted gene 13375 N/A 
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69.  Kifc5b Kinesin family member C5B Microtubule binding and microtubule motor 
activity. 
70.  Slc7a8 Solute carrier family 7 (cationic amino 
acid transporter, y+ system) member 8 
 
Large and neutral amino acid transmembrane 
transport. 
71.  C1qa Complement component 1, q 
subcomponent, alpha polypeptide 
Complement activation, classical pathway, 
immune system process, 
72.  Gm10540 Predicted gene 10540 N/A 
73.  Gm10153 Predicted gene 10153 N/A 
74.  Tsga10ip Testis specific 10 interacting protein 
 
 
N/A 
75.  Cir1 Corepressor interacting with RBPJ, 1 
Recombining binding 
proteinsuppressor of hairless  
Required for RBPJ-mediated repression of 
transcription 
 
76.  Hmgb3 High mobility group box 3 Negative regulation of myeloid cell 
differentiation 
77.  Ormdl3 ORM1-like 3 Ceramide metabolic process. Negative 
regulator of sphingolipid synthesis. May 
indirectly regulate endoplasmic reticulum-
mediated calcium signalling 
78.  5430421N
21Rik 
RIKEN cdna 5430421N21 gene Human homolog KRT83, keratin 83, 
intermediate filament (cytoskeleton) 
79.  Krt8 Keratin, type II cytoskeletal 8, 
cytokeratin8 
Maintains cellular structural integrity and 
cellular differentiation. TNF-mediated 
signalling pathway.  
80.  Cnn3 Calponin 3, acidic Thin filament-associated protein. Binds to 
actin, calmodulin, troponin C and tropomyosin. 
Interaction of calponin with actin inhibits 
actomyosin Mg-ATPase activity. 
81.  Acsf2 Acyl-CoA synthetase family member 2 Acyl-CoA synthases catalyze the initial reaction 
in fatty acid metabolism.  
82.  F2r F2r coagulation factor II (thrombin) 
receptor, (Proteinase-activated 
receptor 1 (PAR1)) 
Regulation of thrombotic response. 
83.  C1qb C1qb complement component 1, q 
subcomponent, beta polypeptide 
Immune and stress response. 
84.  Cd83 CD83 antigen Immune response, antigen presentation and 
cellular interactions that follow lymphocyte 
activation 
85.  Vmn2r4 Vomeronasal 2, receptor 4 GPCR, putative pheromone receptor. 
86.  Hs6st2 Heparan sulfate 6-O-sulfotransferase 2 Heparan sulfate proteoglycans are molecules 
in cell surface, ECM & basement membranes. 
Involved in cell growth, differentiation, 
adhesion, and migration. Hs6st2 catalyzes the 
transfer of sulfate to HS. 
87.  Gm9025 Predicted gene 9025  
88.  H2-Aa H2-Aa histocompatibility 2, class II 
antigen A, alpha 
Immune response 
89.  Vmn1r59 Vomeronasal 1 receptor 59 GPCR, pheromone receptor. 
90.  Serpine2 Serpine2 serine (or cysteine) peptidase 
inhibitor, clade E, member 2 
Serine protease inhibitor with activity toward 
thrombin, trypsin, and urokinase. Promotes 
neurite extension by inhibiting thrombin. Binds 
heparin. 
91.  Hsd3b1 Hydroxy-delta-5-steroid 
dehydrogenase, 3 beta- and steroid 
delta-isomerase 1 
Possible steroid biosynthetic process 
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92.  Ube2c Ubiquitin-conjugating enzyme E2C Ubiquitin-protein ligase activity 
93.  Mcpt4 Mast cell protease 4 Proteolysis 
94.  Tgm2 Transglutaminase 2, C polypeptide Protein crosslinking 
95.  Ptgs1 Prostaglandin-endoperoxide synthase 
1 (COX-1) 
 
96.  Txlng Taxilin gamma Intracellular vesicle trafficking 
97.  Igkv8-30 Immunoglobulin kappa chain variable 
8-30 
Immune response 
98.  Lsm6 Lsm6 homolog, U6 small nuclear RNA 
associated (S. cerevisiae) 
Involved in RNA processing 
99.  Gm4968 Predicted gene 4968  
100. Ccl17 Chemokine (C-C motif) ligand 17 Induces chemotaxis in T cells 
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Table S3. Differentially expressed genes (≥2.0-absolute-fold-change, P<0.05) following 
proton activation of OGR1 in murine macrophages. pH 6.7 24 h.  
 
 
 
 
 
 
 
 
 
 
Entrez 
Gene No. Symbol/gene Gene Name 
20344 Selp Selectin P (Granule Membrane Protein 140kDa) 
13653 Egr1 Early Growth Response 1 
20299 Ccl22 Chemokine (C-C Motif) Ligand 22 
12156 Bmp2 Bone morphogenetic protein 2 
18787 PAI-1 Serpine1 
57349 Ppbp Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) 
23886 Gdf15 Growth Differentiation Factor  
14131 Fcgr3 Fc receptor, IgG, low affinity III (CD16) 
246256 Fcgr4 Fc receptor, IgG, low affinity IV (CD16-2) 
15370 Nr4a1 Nuclear receptor subfamily 4 
20343 Sell Selectin, CD62L 
54123 Irf7 Interferon Regulatory Factor 7 
21825 Thbs1 Thrombospondin 1 
67603 Dusp6 Dual Specificity Phosphatase 6 
29817  Igfbp7/8 Insulin-Like Growth Factor Binding Protein 7 
16323 Inhba Activin 
20692 Sparc Osteonectin 
17228 Cma1 Chymase 
641340 Nrbf2 Nuclear receptor binding factor 2 
17227 Mcpt4 Mcpt4  mast cell protease 4  
20379 Sfrp4 Secreted frizzled-related protein 4 
14129 Fcgr1 Fc Fragment Of IgG, High Affinity Ia, Receptor (CD64) 
22339 Vegfa Vascular endothelial growth factor A 
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